Cytosorbents (CTSO) Reports In-Line Q2 EPS

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $9.59 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Oak Valley Bancorp (OVLY) Tops Q2 EPS by 61c
• Knowles (KN) Tops Q2 EPS by 2c, Offers Guidance